Shuttle Pharmaceuticals Holdings, Inc. financial data

Symbol
SHPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
401 Professional Drive, Suite 260, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 156 % -81.4%
Debt-to-equity 263 % +581%
Return On Equity -1.24K % -1003%
Return On Assets -340 % -321%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.08M shares -75.7%
Common Stock, Shares, Outstanding 4.08M shares +103%
Entity Public Float 4.1M USD -65%
Common Stock, Value, Issued 41 USD +105%
Weighted Average Number of Shares Outstanding, Basic 2.87M shares +53.8%
Weighted Average Number of Shares Outstanding, Diluted 2.89M shares +54.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.62M USD +2.89%
General and Administrative Expense 1.39M USD +33%
Operating Income (Loss) -7.7M USD -30.6%
Nonoperating Income (Expense) -1.45M USD -107%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.78M USD -77.8%
Net Income (Loss) Attributable to Parent -9.14M USD -38.7%
Earnings Per Share, Basic -3.19 USD/shares +9.63%
Earnings Per Share, Diluted -3.3 USD/shares +6.52%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.92M USD -25.5%
Marketable Securities, Current 1.64M USD -43.4%
Other Assets, Current 81.5K USD
Assets, Current 2.21M USD -60.5%
Property, Plant and Equipment, Net 19.4K USD -22%
Operating Lease, Right-of-Use Asset 276K USD -17.3%
Assets 2.51M USD -57.9%
Liabilities, Current 1.53M USD +47.2%
Operating Lease, Liability, Noncurrent 238K USD -21.7%
Liabilities 1.8M USD -5.21%
Retained Earnings (Accumulated Deficit) -34.6M USD -36%
Stockholders' Equity Attributable to Parent 709K USD -82.5%
Liabilities and Equity 2.51M USD -57.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.24M USD +7.39%
Net Cash Provided by (Used in) Financing Activities -40K USD -101%
Net Cash Provided by (Used in) Investing Activities 101K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.08M shares +103%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.18M USD +5.62%
Interest Paid, Excluding Capitalized Interest, Operating Activities 79K USD
Deferred Tax Assets, Valuation Allowance 5.06M USD +49.7%
Deferred Tax Assets, Gross 5.07M USD +48%
Operating Lease, Liability 299K USD -16.2%
Depreciation 1.91K USD +28.5%
Lessee, Operating Lease, Liability, to be Paid 360K USD -20.3%
Property, Plant and Equipment, Gross 127K USD
Operating Lease, Liability, Current 60.9K USD +16.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 97.1K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 94.2K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 60.5K USD -35.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 100K USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 3M USD +73.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 68.2K USD -31.8%
Operating Lease, Payments 91.5K USD -4.33%
Additional Paid in Capital 35.3M USD +19.7%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 623K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%